EUVIMEDEUVIMED entdecken
Open Access

Relationship of Fat Mass Ratio, a Biomarker for Lipodystrophy, With Cardiometabolic Traits

Saaket Agrawal iD, Jian'an Luan, Beryl B Cummings, Ethan J Weiss, Nick J Wareham, Amit V Khera

Diabetes · 01.07.2024 · 73 (7) · 1099-1111

DOI: 10.2337/db23-0575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, online erschienen am 12.02.2024. Verfasst von Saaket Agrawal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA. Hauptthemen laut MEDLINE: Biomarkers. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, Sarnoff Cardiovascular Research Foundation, National Human Genome Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial partial lipodystrophy (FPLD) is a heterogenous group of syndromes associated with a high prevalence of cardiometabolic diseases. Prior work has proposed DEXA-derived fat mass ratio (FMR), defined as trunk fat percentage divided by leg fat percentage, as a biomarker of FPLD, but this metric has not previously been characterized in large cohort studies. We set out to 1) understand the cardiometabolic burden of individuals with high FMR in up to 40,796 participants in the UK Biobank and 9,408 participants in the Fenland study, 2) characterize the common variant genetic underpinnings of FMR, and 3) build and test a polygenic predictor for FMR. Participants with high FMR were at higher risk for type 2 diabetes (odds ratio [OR] 2.30, P = 3.5 × 10−41) and metabolic dysfunction–associated liver disease or steatohepatitis (OR 2.55, P = 4.9 × 10−7) in UK Biobank and had higher fasting insulin (difference 19.8 pmol/L, P = 5.7 × 10−36) and fasting triglycerides (difference 36.1 mg/dL, P = 2.5 × 10−28) in the Fenland study. Across FMR and its component traits, 61 conditionally independent variant-trait pairs were discovered, including 13 newly identified pairs. A polygenic score for FMR was associated with an increased risk of cardiometabolic diseases. This work establishes the cardiometabolic significance of high FMR, a biomarker for FPLD, in two large cohort studies and may prove useful in increasing diagnosis rates of patients with metabolically unhealthy fat distribution to enable treatment or a preventive therapy. Article Highlights

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersHumansFemaleMaleMiddle AgedAdultLipodystrophy, Familial PartialDiabetes Mellitus, Type 2Adipose TissueCardiovascular Diseases

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA.
  • Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Department of Medicine, Harvard Medical School, Boston, MA.
  • MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge Biomedical Campus, Cambridge, U.K.
  • Marea Therapeutics, San Francisco, CA.
  • Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA.

ORCID-Profile: Saaket Agrawal

Förderung

  • NHGRI NIH HHS
  • Sarnoff Cardiovascular Research Foundation
  • National Human Genome Research Institute

Zitieren

APA

Agrawal, S., Luan, J., Cummings, B. B., Weiss, E. J., Wareham, N. J., & Khera, A. V. (2024). Relationship of Fat Mass Ratio, a Biomarker for Lipodystrophy, With Cardiometabolic Traits. Diabetes, 73(7), 1099-1111. https://doi.org/10.2337/db23-0575

Vancouver

Agrawal S, Luan J, Cummings BB, Weiss EJ, Wareham NJ, Khera AV. Relationship of Fat Mass Ratio, a Biomarker for Lipodystrophy, With Cardiometabolic Traits. Diabetes. 2024;73(7):1099-1111. doi:10.2337/db23-0575

BibTeX
@article{Agrawal2024,
  author = {Agrawal, Saaket and Luan, Jian'an and Cummings, Beryl B and Weiss, Ethan J and Wareham, Nick J and Khera, Amit V},
  title = {Relationship of Fat Mass Ratio, a Biomarker for Lipodystrophy, With Cardiometabolic Traits},
  journal = {Diabetes},
  year = {2024},
  volume = {73},
  number = {7},
  pages = {1099--1111},
  doi = {10.2337/db23-0575}
}
Kostenlos starten →